Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...

Researchers have created a novel imaging-technology combination that can capture gene activity in individual bacteria in ...

MUNICH, Germany I January 30, 2025 I Ethris GmbH, a leading biotechnology company pioneering next-generation RNA therapeutics and vaccines ... Ethris filed a Clinical Trial Application (CTA) for a ...

Government data has shown a spike in Rhinovirus cases, especially in young kids, with the positivity rate increasing from 8.1% last week to 9.7%. Although there is no specific figure for the ...

These topline results provide the first clinical validation of Ethris’ pioneering targeted RNA therapeutic approach ... for a Phase 2a rhinovirus challenge study in asthma patients, planned ...

These topline results provide the first clinical validation of Ethris’ pioneering targeted RNA therapeutic approach and its ability ... Ethris filed a Clinical Trial Application (CTA) for a Phase 2a ...

A recent study has highlighted how DNA may hold the key to developing innovative therapies that could change the face of medicine. DNA, or deoxyribonucleic acid, is the molecule that contains the ...

Often wrongly called the “stomach flu,” norovirus sickens tens of millions of Americans annually. Two physicians explain how to prevent and treat it. It seems as though everyone has experienced a ...